Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care.

I N Bruce, M Urowitz, R van Vollenhoven, C Aranow, J Fettiplace, M Oldham, B Wilson, C Molta, D Roth, D Gordon

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care.'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science